Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus

References

1. Ada G. L., Jones P. D. 1986; The immune response to influenza infection. Current Topics in Microbiology and Immunology 128:2–54
   [Google Scholar]
2. Aderka D., Novick D., Hahn T., Fischer D. G., Wallach D. 1985; Increase in vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon. Cellular Immunology 92:218–225
   [Google Scholar]
3. Bachwich P. R., Chensue S. W., Larrick J. W., Kunkel S. L. 1986; Tumor necrosis factor stimulates interleukin 1 and prostaglandin E2 production in resting macrophages. Biochemical and Biophysical Research Communications 136:94
   [Google Scholar]
4. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A., O’Connor J. V. 1986; Tumor necrosis factor (TNF) is an endogenous pyrogen and induces production of interleukin 1. Journal of Experimental Medicine 163:1433–1449
   [Google Scholar]
5. Fish H., Gifford G. E. 1983; A photometric and plaque assay for macrophage-mediated tumor cell cytotoxicity. Journal of Immunological Methods 57:311–325
   [Google Scholar]
6. Fujisawa H., Tsuru S., Taniguchi M., Zinnaka Y., Nomoto K. 1987; Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. Journal of General Virology 68:425–432
   [Google Scholar]
7. Le J., Vilcek J. 1987; Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Laboratory Investigation 56:234–248
   [Google Scholar]
8. Mestan J., Digel W., Mittnacht S., Hillen H., Blohm D., Moeller A. 1986; Antiviral effects of recombinant tumor necrosis factor in vitro. Nature; London: 323816–819
   [Google Scholar]
9. Ming W. J., Bersani L., Mantovani A. 1987; Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. Journal of Immunology 138:1469–1474
   [Google Scholar]
10. Mitchell D. M., McMichael A. J., Lamb J. R. 1985; The immunology of influenza. British Medical Bulletin 41:80–85
    [Google Scholar]
11. Roberts N. J., Prill A. J., Mann T. N. 1986; Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity. Journal of Experimental Medicine 163:511–519
    [Google Scholar]
12. Rudent A., Zalisz R., Quero A. M., Smets P. 1985; Enhanced resistance of mice against influenza virus infection after local administration of glycoprotein extracts from Klebsiella pneumoniae. International Journal of Immunopharmacology 7:525–531
    [Google Scholar]
13. Rudent A., Michel F., Labarre C., Quero A. M., Zalisz R., Smets P. 1987; Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU-41821 aerosol. Antimicrobial Agents and Chemotherapy 31:921–924
    [Google Scholar]
14. Van Damme J., Deley H., Van Snick J., Dinarello C. A., Billiau A. 1987; The role of interferon-βl and the 26-kd a protein (interferon β) as mediators of the antiviral effect of interleukin-1 and tumor necrosis factor. Journal of Immunology 139:1867–1872
    [Google Scholar]
15. Warr G. A., Jakab G. J. 1983; Pulmonary inflammatory responses during viral pneumonia and secondary bacterial infection. Inflammation 7:93–104
    [Google Scholar]